Rituxan/BEAM vs Bexxar/BEAM in Autologous Hematopoietic Stem Cell Transplant for Non-Hodgkin's Lymphoma (BMTCTN0401)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Mary Horowitz, MD
Center for International Blood and Marrow Transplant Research
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
36 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Yale University School of Medicine
New Haven, Connecticut, United States
- University of Florida College of Medicine (shands)
Gainesville, Florida, United States
- University of Miami
Miami, Florida, United States
- H. Lee Moffitt Cancer Center
Tampa, Florida, United States
- Emory University
Atlanta, Georgia, United States
- St. Lukes Mountain States Tumor Institute
Boise, Idaho, United States
- Loyola University Medical Center
Maywood, Illinois, United States
- University of Iowa Hospitals and Clinics
Iowa City, Iowa, United States
- Johns Hopkins/skccc
Baltimore, Maryland, United States
- University of Maryland Medical Systems/greenbaum Cancer Center
Baltimore, Maryland, United States
- Tufts-New England Medical Center
Boston, Massachusetts, United States
- University of Michigan Medical Center
Ann Arbor, Michigan, United States
- University of Minnesota
Minneapolis, Minnesota, United States
- Washington University/barnes Jewish Hospital
St Louis, Missouri, United States
- University of Nebraska
Omaha, Nebraska, United States
- Hackensack University Medical Center
Hackensack, New Jersey, United States
- Memorial Sloan-Kettering Cancer Center
New York, New York, United States
- Weill Cornell Medical College, the New York Presbyterian Hospital
New York, New York, United States
- University of Rochester Medical Center
Rochester, New York, United States
- University of North Carolina Hospital at Chapel Hill
Chapel Hill, North Carolina, United States
- Duke University Medical Center
Durham, North Carolina, United States
- University Hospitals of Cleveland/case Western
Cleveland, Ohio, United States
- Columbia River Oncology Program
Portland, Oregon, United States
- Providence Portland Medical Center
Portland, Oregon, United States
- University of Pennsylvania Cancer Center
Philadelphia, Pennsylvania, United States
- Medical University of South Carolina
Charleston, South Carolina, United States
- Cancer Centers of the Carolinas
Greenville, South Carolina, United States
- Vanderbilt University Medical Center
Nashville, Tennessee, United States
- Baylor University Medical Center
Dallas, Texas, United States
- Texas Transplant Institute
San Antonio, Texas, United States
- Intermountain Bmt Program
Salt Lake City, Utah, United States
- University of Utah Medical School, Bmt
Salt Lake City, Utah, United States
- Virginia Commonwealth University/mcv Hospital
Richmond, Virginia, United States
- Fred Hutchinson Cancer Research Center
Seattle, Washington, United States
- University of Wisconsin Hospital and Clinics
Madison, Wisconsin, United States
- Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2005
- Primary completion
- 31 Aug 2013
- Completion
- 31 Aug 2013
- Last update posted
- 1 Nov 2021
- Registered enrollment
- 224
- Registry id
- NCT00329030
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.